FocusCancer

Resurrecting DNAzymes as Sequence-Specific Therapeutics

See allHide authors and affiliations

Science Translational Medicine  20 Jun 2012:
Vol. 4, Issue 139, pp. 139fs20
DOI: 10.1126/scitranslmed.3004080

You are currently viewing the abstract.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

Abstract

In a mouse model of skin cancer, intratumoral injection of a sequence-specific mRNA-cleaving DNA enzyme caused potent inhibition of tumor growth and unusually benign pharmacodynamic profiles.

View Full Text